Global Rising Stars Outlook 2015: Innovative Therapies for Treating Diseases are Being Sought after with Fresh Vigor as New Targets
Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.
Key Criteria for Our Selection are:-
Key Criteria for Our Selection are:-
- Uniqueness of the Technology platform and the ability to scale up commercially in case of positive outcome of products in the pipeline
- Pipeline and clinical data analysis
- Marketed product and commercial tie up. Robustness of the Management, financial and business model.
CESCA THERAPEUTICS INC.: HEDGING THE RISK WITH STEM CELL BASED DEVICES AND THERAPIES AND GLOBAL PRESENCE
Figure 1: Products In Pipeline
Table 1: Clinical Development- Critical Limb Ischemia (ClI)Data Key Milestones
OCATA THERAPEUTICS INC: OPHTHALMIC FOCUS- MACULAR DEGENERATIVE CONDITIONS- LOOKING WITH A NEW EYE
Figure 1: Market For Age-Related Macular Degeneration (AMD)
Figure 2: Products In The Pipeline
ORGENESIS: FOCUS- DIABETES- TRICKING YOUR LIVER TO MAKE INSULIN!
Technology Platform
Figure 1: Schematic Representation Of Making Autologous Insulin Producing (AIP) Cell
TIGENIX NV: EXPLOITING THE ADIPOSE TISSUE- MULTIPLE APPLICATIONS OF FAT?
Technology Platform
Marketed Products
Figure 1: Products In Pipeline
Key Milestones
PLURISTEM THERAPEUTICS INC: REGENERATING AND RECYCLING- ALLOGENIC THERAPIES FROM THE PLACENTA
PluriX 3D Technology Platform
Pipeline
Figure 1: Classification Of Peripheral Arterial Disease Types
Market Opportunity
Key Milestones
MESOBLAST: LEADER IN REGENERATIVE SAPCE IN KOREA- FOCUSING ON INTERNATIONAL MARKETS
Technology Platform
Pipeline- Focus on four major areas
Figure 1: Drugs In The Pipeline
Figure 2: CHFf Discease Classification And Target Patients In PhIII Trial
Figure 3: PhiII Data Of MPC-150 In CHF
Figure 4: Market Opportunity In Chronic Low Back Pain (CLBP)
Key Milestones
MEDIPOST CO LTD: LEADER IN REGENERATIVE SPACE IN KOREA- FOCUSING ON INTERNATIONAL MARKETS
Marketed and Products in the Pipeline
Key Milestones
Figure 1: Sales By Business Segment
JCR PHARMACEUTICALS CO. LTD.: FIRST STEM CELL BASED PRODUCT IN JAPAN FOR GRAFT-VERSUS-HOST DISEASE (GVHD).
Technology Platform
Product in the Pipeline
Key Milestones
Facts and Financials
Table 1: Pipeline Table
Figure 1: Sales By Business Segments
JAPAN TISSUE ENGINEERING CO. LTD: BUILDING CONFIDENCE IN REGENERATIVE MEDICINE- FUJI FILM VENTURE FROM COLORS TO REGENERATIVE MEDICINE-
Plat form Focus
Products
Figure 1: Therapy and Product Focus
PART II-INDIAN INNOVATORS- RISING STARS:
Table 1: Select new generation innovation /drug discovery Indian companies
Connexios: Maturing Pipeline and Focus on Diabetes/Metabolic Disorders to Drive Visibility
Technology Platform
Therapy Focus—Diabetes/Metabolic Disorder and Non Alcoholic Steatohepatitis (NASH)
Key Milestones
Table 1: Differences Between G-Protein Coupled Receptor Agonists
Table 2: Pipeline Of GPR Agonist For Treatment Of Type 2 Diabetes
Figure 1: Products In Pipeline- Diabetes
Figure 2: Products In Pipeline For NASH
Figure 3: Other Programs
CELLWORKS: IN SILICO TECHNOLOGY PLATFORM POISED TO DELIVER- FOCUS ON PERSONALISED MEDICINE AND CANCER
Figure 1: Simulation Based Personalized Medicine
Figure 2: Cellworks Therapeutic Programs
BUGWORKS: IN SILICO TECHNOLOGY PLATFORM BEING APPLIED TO SERIOUS HOSPITAL INFECTIONS- NEED OF THE HOUR!
Therapy focus- Serious Hospital Infection
Technology Platform
Figure 1: Drug Development Success For TB
Figure 2: Going Way Froward
TERGENE: AFFORDABLE AND SECOND GENERATION VACCINES- ADDRESSING THE URGENT NEEDS OF EMERGING MARKETS.
Development Strategy and Status
Figure 1: Sales Of Currently Available Vaccines For Streptococcus Pneumonia
Figure 2: WW Demand Forecast Of Vaccines For Streptococcus Pneumonia
Figure 3: Vaccine Market
Figure 1: Products In Pipeline
Table 1: Clinical Development- Critical Limb Ischemia (ClI)Data Key Milestones
OCATA THERAPEUTICS INC: OPHTHALMIC FOCUS- MACULAR DEGENERATIVE CONDITIONS- LOOKING WITH A NEW EYE
Figure 1: Market For Age-Related Macular Degeneration (AMD)
Figure 2: Products In The Pipeline
ORGENESIS: FOCUS- DIABETES- TRICKING YOUR LIVER TO MAKE INSULIN!
Technology Platform
Figure 1: Schematic Representation Of Making Autologous Insulin Producing (AIP) Cell
TIGENIX NV: EXPLOITING THE ADIPOSE TISSUE- MULTIPLE APPLICATIONS OF FAT?
Technology Platform
Marketed Products
Figure 1: Products In Pipeline
Key Milestones
PLURISTEM THERAPEUTICS INC: REGENERATING AND RECYCLING- ALLOGENIC THERAPIES FROM THE PLACENTA
PluriX 3D Technology Platform
Pipeline
Figure 1: Classification Of Peripheral Arterial Disease Types
Market Opportunity
Key Milestones
MESOBLAST: LEADER IN REGENERATIVE SAPCE IN KOREA- FOCUSING ON INTERNATIONAL MARKETS
Technology Platform
Pipeline- Focus on four major areas
Figure 1: Drugs In The Pipeline
Figure 2: CHFf Discease Classification And Target Patients In PhIII Trial
Figure 3: PhiII Data Of MPC-150 In CHF
Figure 4: Market Opportunity In Chronic Low Back Pain (CLBP)
Key Milestones
MEDIPOST CO LTD: LEADER IN REGENERATIVE SPACE IN KOREA- FOCUSING ON INTERNATIONAL MARKETS
Marketed and Products in the Pipeline
Key Milestones
Figure 1: Sales By Business Segment
JCR PHARMACEUTICALS CO. LTD.: FIRST STEM CELL BASED PRODUCT IN JAPAN FOR GRAFT-VERSUS-HOST DISEASE (GVHD).
Technology Platform
Product in the Pipeline
Key Milestones
Facts and Financials
Table 1: Pipeline Table
Figure 1: Sales By Business Segments
JAPAN TISSUE ENGINEERING CO. LTD: BUILDING CONFIDENCE IN REGENERATIVE MEDICINE- FUJI FILM VENTURE FROM COLORS TO REGENERATIVE MEDICINE-
Plat form Focus
Products
Figure 1: Therapy and Product Focus
PART II-INDIAN INNOVATORS- RISING STARS:
Table 1: Select new generation innovation /drug discovery Indian companies
Connexios: Maturing Pipeline and Focus on Diabetes/Metabolic Disorders to Drive Visibility
Technology Platform
Therapy Focus—Diabetes/Metabolic Disorder and Non Alcoholic Steatohepatitis (NASH)
Key Milestones
Table 1: Differences Between G-Protein Coupled Receptor Agonists
Table 2: Pipeline Of GPR Agonist For Treatment Of Type 2 Diabetes
Figure 1: Products In Pipeline- Diabetes
Figure 2: Products In Pipeline For NASH
Figure 3: Other Programs
CELLWORKS: IN SILICO TECHNOLOGY PLATFORM POISED TO DELIVER- FOCUS ON PERSONALISED MEDICINE AND CANCER
Figure 1: Simulation Based Personalized Medicine
Figure 2: Cellworks Therapeutic Programs
BUGWORKS: IN SILICO TECHNOLOGY PLATFORM BEING APPLIED TO SERIOUS HOSPITAL INFECTIONS- NEED OF THE HOUR!
Therapy focus- Serious Hospital Infection
Technology Platform
Figure 1: Drug Development Success For TB
Figure 2: Going Way Froward
TERGENE: AFFORDABLE AND SECOND GENERATION VACCINES- ADDRESSING THE URGENT NEEDS OF EMERGING MARKETS.
Development Strategy and Status
Figure 1: Sales Of Currently Available Vaccines For Streptococcus Pneumonia
Figure 2: WW Demand Forecast Of Vaccines For Streptococcus Pneumonia
Figure 3: Vaccine Market